Bicycle Therapeutics plc (50BA) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.119x

Based on the latest financial reports, Bicycle Therapeutics plc (50BA) has a cash flow conversion efficiency ratio of -0.119x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-65.92 Million ≈ $-77.07 Million USD) by net assets (€554.32 Million ≈ $648.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bicycle Therapeutics plc (50BA) defensive interval to measure how many days the company can operate on defensive assets alone.

Bicycle Therapeutics plc - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Bicycle Therapeutics plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bicycle Therapeutics plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bicycle Therapeutics plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Monash Ivf Group Ltd AU:MVF	0.051x
Hyundai Corp KO:011760	-0.296x
AIRA Capital Public Company Limited BK:AIRA	0.109x
Xplora Technologies As OL:XPLRA	0.295x
Bursa Cimento Fabrikasi AS IS:BUCIM	0.017x
Huxen Corp TW:2433	0.060x
Skue Sparebank OL:SKUE	0.056x
Indomobil Sukses Internasional JK:IMAS	-0.199x

Annual Cash Flow Conversion Efficiency for Bicycle Therapeutics plc (2018–2025)

The table below shows the annual cash flow conversion efficiency of Bicycle Therapeutics plc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Bicycle Therapeutics plc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€609.98 Million ≈ $713.13 Million	€-249.68 Million ≈ $-291.90 Million	-0.409x	-97.07%
2024-12-31	€793.06 Million ≈ $927.17 Million	€-164.72 Million ≈ $-192.58 Million	-0.208x	-76.51%
2023-12-31	€370.93 Million ≈ $433.66 Million	€-43.65 Million ≈ $-51.03 Million	-0.118x	+63.00%
2022-12-31	€270.78 Million ≈ $316.57 Million	€-86.11 Million ≈ $-100.67 Million	-0.318x	-644.30%
2021-12-31	€346.25 Million ≈ $404.81 Million	€-14.79 Million ≈ $-17.30 Million	-0.043x	+77.07%
2020-12-31	€95.46 Million ≈ $111.60 Million	€-17.79 Million ≈ $-20.80 Million	-0.186x	+39.30%
2019-12-31	€93.20 Million ≈ $108.96 Million	€-28.61 Million ≈ $-33.45 Million	-0.307x	-182.21%
2018-12-31	€-69.83 Million ≈ $-81.63 Million	€-26.08 Million ≈ $-30.49 Million	0.373x	--

About Bicycle Therapeutics plc

F:50BA Germany Biotechnology

Market Cap

$202.59 Million

€173.28 Million EUR

Market Cap Rank

#16597 Global

#1575 in Germany

Share Price

€3.44

Change (1 day)

+1.78%

52-Week Range

€3.38 - €7.80

All Time High

€52.00